TABLE 5.

Changes in co‐administered medications throughout treatment with cannabis‐based medicinal products after 12 months in study participants (n = 68).

Medication	Total	Stopped taking	Reduced dose	No change	Increased dose	New medication
Methylphenidate, n (%)	20	3 (15.00%)	0 (0.00%)	14 (70.00%)	0 (0.00%)	3 (15.00%)
Lisdexamfetamine, n (%)	13	5 (38.46%)	0 (0.00%)	8 (61.54%)	0 (0.00%)	0 (0.00%)
Atomoxetine, n (%)	6	0 (0.00%)	0 (0.00%)	6 (100.00%)	0 (0.00%)	0 (0.00%)
Dexamfetamine, n (%)	7	1 (14.29%)	0 (0.00%)	4 (57.14%)	0 (0.00%)	2 (28.57%)